Pages with the fewest revisions

Showing below up to 50 results in range #51 to #100.

51. Outreach (2 revisions)
52. Biotechnology - Genomic and Proteomics/History PCR (2 revisions)
53. Diagnostic Kits/Patents and translational research in genomics (2 revisions)
54. Legislation on Policy Theme 3 for EM (2 revisions)
55. John Liebovitz Feedback Notes (2 revisions)
56. Peter Mandelstam (2 revisions)
57. Industrial Cooperation Project/ICP Questions (3 revisions)
58. Diagnostic Kits/Open Business models in Kits (3 revisions)
59. Legislation on Policy Theme 9 for EM (3 revisions)
60. Diagnostic Kits/Models for facilitating access to patents on genetic inventions (3 revisions)
61. Kathi Fletcher Interview Notes - August 26, 2009 (3 revisions)
62. Bill Hughes Interview Notes - October 7, 2009 (3 revisions)
63. /Diagnostic Kits/Nature on open data (3 revisions)
64. Diagnostic Kits/DNA-based patents: an empirical analysis (3 revisions)
65. Legislation on Policy Theme 5 for EM (3 revisions)
66. Alternative Energy/EFRCs Survey Questions (3 revisions)
67. Michael Dworkin (3 revisions)
68. Diagnostic Kits/Analysing DNA patents in relation with diagnostic genetic testing (3 revisions)
69. Legislation on Policy Theme 2 for EM (3 revisions)
70. Jonathan Emmons Interview Notes - March 25, 2009 (3 revisions)
71. Possible journal or working paper submission sites (3 revisions)
72. Lessons from ANT (3 revisions)
73. Diagnostic Kits/Diagnostic Test Service Commercialization- A Roadmap to Diagnostics in the 21st Century (3 revisions)
74. Diagnostic Kits/A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions (3 revisions)
75. Diagnostic Kits/SACGHS U.S. System of Oversight of Genetic Testing (3 revisions)
76. New Energy Movement Director (3 revisions)
77. Diagnostic Kits/Disease Gene Patents (3 revisions)
78. Benkler (3 revisions)
79. Legislation on Policy Theme 6 for EM (3 revisions)
80. Eric Frank Interview Notes - October 22, 2009 (3 revisions)
81. Biotechnology - Genomic and Proteomics/Peer-Production Models in BGP (3 revisions)
82. Diagnostic Kits/Morrison and Foerster Represents ACON Laboratories in $175 Million Acquisition by Inverness Medical Innovations (3 revisions)
83. Boyle (3 revisions)
84. Australia Country Report (3 revisions)
85. Diagnostic Kits/Testing new ground (3 revisions)
86. Diagnostic Kits/Nature on Open Data (3 revisions)
87. Diagnostic Kits/The Manchester Manifesto (3 revisions)
88. Legislation on Policy Theme 8 for EM (3 revisions)
89. EurObserv-ER reports (3 revisions)
90. Diagnostic Kits/The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care (3 revisions)
91. Adam Holland (3 revisions)
92. Legislation on Policy Theme 4 for EM (3 revisions)
93. Anne Schreiber Interview Notes - August 31, 2009 (3 revisions)
94. Diagnostic Kits/A pilot survey on the licensing of DNA inventions (3 revisions)
95. Diagnostic Kits/Diagnostics and biomarker development- priming the pipeline (3 revisions)
96. Telecommunications/Background Research and Resources (3 revisions)
97. William Bonvillian (3 revisions)
98. Anne Schreiber Interview Notes - August 27, 2009 (4 revisions)
99. Alternative Energy/Innovation and Technology Transfer to Address Climate Change (4 revisions)
100. Diagnostic Kits/Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing (4 revisions)